Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Item No. 10012559

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Thromboxane A2 (TXA2) is a potent vasoconstrictor and activator of platelet aggregation. The short half-
WARNING This product is not for human or veterinary use.
1. Platelets, thrombosis, and antithrombotic therapies. Cardiovascular Pharmacology 3rd ed., 515-539 (1990).
2. Therapeutic potential of thromboxane inhibitors in asthma. Expert Opin. Investig. Drugs 11(2), 1-8 (2003).
3. Coronary arterial smooth muscle contraction by a substance released from platelets: Evidence that it is thromboxane A2. Science 193(4258), 1135-1137 (1976).
4. Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature. J. Pharmacol. Exp. Ther. 301(3), 1060-1066 (2002).
5. Platelet Prostanoid Receptors. Pharmacotherapy 72(3), 171-191 (1996).
6. Mouse thromboxane A2 receptor: cDNA cloning, expression and Northern blot analysis. Biochem. Biophys. Res. Commun. 184(3), 1197-1203 (1992).
7. Structure and expression of the murine thromboxane A2 receptor gene. Biochem. Biophys. Res. Commun. 256(2), 391-397 (1999).
8. Characterization by photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 receptor: Evidence for N-
9. Immunolocalization of rat thromboxane receptor in the kidney. Endocrinology 137(11), 5170-5173 (1996).
10. Mechanism of platelet inhibition by nitric oxide: In vivo phosphorylation of thromboxane receptor by cyclic GMP-
11. Phosphorylation of the thromboxane receptor α, the predominant isoform expressed in human platelets. The Journal of Biological Chemisty 274(5), 2645-2651 (1999).